<?xml version="1.0" encoding='utf-8'?>
<!DOCTYPE wml PUBLIC "-//WAPFORUM//DTD WML 1.1//EN" "http://www.wapforum.org/DTD/wml_1.1.xml">
<wml>
<card id="card1" title="Bioavailability - Page 17 - Wikipedia">
<p>
<a accesskey="1" href="page.php?w=bioavailability&amp;p=16">1.Previous</a><br />
<a accesskey="3" href="page.php?w=bioavailability&amp;p=18">3.Next</a>
</p>
<p>"brand name drug" is within the limits of 80% to 125%. Where AUC refers to the concentration of the drug in the blood over time t = 0 to t = ?, C<sub>max</sub> refers to the maximum concentration of the drug in the blood. When T<sub>max</sub> is given, it refers to the time it takes for a drug to reach C<sub>max</sub>.</p>

<p>While the mechanisms by which a formulation affects bioavailability and bioequivalence have been extensively studied in drugs, formulation factors that influence bioavailability and bioequivalence in nutritional supplements</p><p>
<a accesskey="1" href="page.php?w=bioavailability&amp;p=16">1.Previous</a><br />
<a accesskey="3" href="page.php?w=bioavailability&amp;p=18">3.Next</a>
</p>

<do type="prev" label="Search">
        <go href="search.wml"/>
</do>

</card>
</wml>
